Connect with us

Hi, what are you looking for?

Entertainment

Rite Aid Files For Bankruptcy Amid Opioid Litigation – One America News Network


SAN RAFAEL, CALIFORNIA - SEPTEMBER 26: The Rite Aid logo is displayed on the exterior of a Rite Aid pharmacy on September 26, 2019 in San Rafael, California. Rite Aid stock surged today after the company reported better-than-expected second-quarter earnings despite revenues falling short. Rite Aid earnings per share rose 12 cents, beating analysts forecasts of 7 cents per share. (Photo by Justin Sullivan/Getty Images)
(Photo by Justin Sullivan/Getty Images)

OAN’s James Meyers
8:35 AM – Monday, October 16, 2023

The drug store Rite Aid has officially filed for bankruptcy.

Advertisement

On Sunday, the company filed for Chapter 11 bankruptcy protection in New Jersey and said that it would begin restructuring to significantly reduce its debt. 

The announcement comes as Rite Aid was known as a runner up to other drug stores and had ongoing legal battles for allegedly filing unlawful opioid prescriptions.

The company recently appointed Jeffrey Stein as their new chief executive officer and chief restructuring officer.

Rite Aid Chairman Bruce Bodaken said in a statement, “Jeff is a proven leader with a strong track record of guiding companies through financial restructurings. We look forward to benefiting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.”

At the end of the most recent quarter, revenue dropped to $5.6 billion, which is down from $6.01 billion from a year-ago. 

With the significant loss of revenue, Rite Aid warned investors it expects to lose between $650 million and $680 million for their fiscal 2024 year. 

According to experts, the loss of revenue is due to less demand of COVID-19 vaccines and testing, a membership reduction in the company’s prescription drug plan and a loss of customers from its Elixir pharmacy benefits.

Advertisement. Scroll to continue reading.

It has also been difficult for Rite Aid to keep up with competitors CVS and Walgreens, as those companies have pivoted to a healthcare focus and have made investments to match. 

In March, the U.S, Department of Justice filed a lawsuit against Rite Aid accusing them of knowingly filling unlawful prescriptions for controlled substances. 

Rite Aid has asked a court to drop the lawsuit and has denied the allegations of unlawfully filling opioid prescriptions. 

Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here. https://www.oann.com/alerts

Advertisement




By: OAN

Loading

Advertisement
Comments

You May Also Like

Biden Administration

In a startling revelation, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has accused the department, under the Biden administration, of being...

Politics

In a recent public statement, U.S. Secretary of State Marco Rubio defended the Trump administration’s sweeping cuts to foreign aid programs, emphasizing the need...

DOGE

In a recent public appearance, Elon Musk, head of the Department of Government Efficiency (Doge), openly ridiculed a $250 million U.S. Department of Labor...

News

An 18-year-old Long Island high school student is taking the tech world by storm with his innovative AI-powered calorie-tracking app — a project now...

Biden Administration

In a contentious interview marking his first 100 days back in office, President Donald Trump directly challenged ABC News correspondent Terry Moran, accusing the...

Democrats

Minnesota Governor Tim Walz is drawing attention following remarks made at Harvard’s Kennedy School in which he explained why then-presidential candidate Kamala Harris selected...

Democrats

In a stunning admission, Democrat Senator Chris Van Hollen has confirmed that U.S. taxpayers footed the bill for his recent trip to El Salvador,...

Crime

A Florida State University student who was seen in a widely circulated video sipping Starbucks during the recent campus tragedy has been identified as...

Advertisement
Back